What the studies show
As a ghrelin mimic, GHRP-2 increased food intake in healthy men in a controlled infusion study — a real acute effect, studied in very few people.
“Similar to what has been reported for ghrelin administration, our subjects ate 35.9 +/- 10.9% more when infused with GHRP-2 vs. saline, with every subject increasing their intake even when calculated per kg body weight (136.0 +/- 13.0 kJ/kg [32.5 +/- 3.1 kcal/kg] vs. 101.3 +/- 10.5 kJ/kg [24.2 +/- 2.5 kcal/kg], p = 0.008).”
A few small or poorly-controlled human studies. Enough to be interesting; not enough to count on. Most of what gets called “clinically proven” online lives here.
- 1Laferrère B, et al. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.J Clin Endocrinol Metab, 2005;90:611–6147 lean men; the appetite data.
In context
GHRP-2, or pralmorelin, is a synthetic six-amino-acid growth-hormone-releasing peptide. It reliably and measurably raises growth hormone, and on that basis is approved in Japan as a diagnostic test for growth-hormone deficiency. Like natural ghrelin it also increases appetite in short human studies. What it does not have is any trial showing it builds muscle, burns fat or improves body composition — the uses it is actually sold for. It is banned in sport.
GHRP-2 is approved (diagnostic, japan). Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is GHRP-2 proven to help with appetite?
What studies are behind the grade?
Is GHRP-2 approved for this?
Other outcomes for GHRP-2
- AGrowth hormone release (diagnostic)Approval-grade diagnostic studies
- DBody compositionNone
- CSafety in humansadverseDiagnostic use
Written and maintained by LYO Research — how pages are written and checked. Reviewed 3 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →